This Solicitation opportunity from Department Of Defense was posted on May 26, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
DEXTROSE AND SODIUM
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract specifies the procurement of Dextrose and Sodium Chloride Injection USP, a sterile, nonpyrogenic, single-dose intravenous solution supplied in 1-liter bags containing 5 grams of anhydrous dextrose and 0.45 grams of sodium chloride per 100 mL, packaged in boxes of 12 bags, latex-free but containing DEHP. Each unit must have an intact seal and clear solution, stored at 20 to 25°C (68 to 77°F) per USP Controlled Room Temperature guidelines, with a nonextendable shelf life of 30 months. Packaging and labeling must comply strictly with MIL-STD-129 and the latest Medical Marking Standard No. 1, with palletization following DLA’s RP001 requirements. The product is regulated by the FDA and requires referral to a product specialist, and if deemed hazardous under FED-STD-313, must be packaged per TQ IP025; otherwise, commercial packaging per ASTM D3951 applies, though DLA’s technical requirements supersede ASTM standards. The delivery is FOB destination to Fort Bragg, North Carolina, with a strict 20-day delivery window from award, no quantity variance allowed, and shipment must occur via fastest traceable means excluding parcel post. The contract utilizes the DoD unit of issue and mandates invoice submission through Wide Area WorkFlow (WAWF), with inspection and acceptance occurring at the destination. The solicitation number is SPE2DP-26-T-3538, issued on May 26, 2026, with responses due June 1, 2026, under a simplified acquisition procedure governed by multiple FAR clauses, including alternative contract types, small business representation, trafficking in persons, sustainable products, and safeguarding covered contractor information systems. The contracting office is under the Department of Defense’s Medical Supply Chain Pharm FSA, with Daniel Porter as the point of contact, and the NSN is 6505-00-116-1025. All contractual obligations are subject to the DLA Master List of Technical and Quality Requirements and require full compliance with security, labeling, and documentation mandates, including Unique Entity Identifier and CAGE code submission, as well as affirmative disclosures regarding covered defense telecommunications equipment or services.
General Info
Agency
NAICS
Place of Performance
BLD A5474 PRATT ST, FORT BRAGG, NC, 28310, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
DEXTROSE AND SODIUM CHLORIDE INJECTION<(>,<)> USP. RX ONLY; STERILE AND
NONPYROGENIC. SINGLE-DOSE CONTAINER. LATEX-FREE; CONTAINS DEHP. FOR
INTRAVENOUS USE ONLY. CONTAINS ONE PORT. EACH 100 ML CONTAINS: HYDROUS
DEXTROSE USP 5 G SODIUM CHLORIDE USP 0.45 G WATER FOR INJECTION USP QS.
UNIT OF ISSUE IS A PACKAGE CONTAINING 12 EACH (BAGS/CONTAINERS). EACH
BAG OR CONTAINER CONTAINS 1,000 ML OR 1 LITER. STORE AT 20 TO 25°C (68
TO 77°F). [SEE USP CONTROLLED ROOM TEMPERATURE.] AVOID EXCESSIVE HEAT
AND PROTECT FROM FREEZING. USE ONLY IF THE SOLUTION IS CLEAR AND SEALS
ARE INTACT.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS019: Shelf-life requirement RS001 for a TYPE I (CODE P) item with a shelf life of 30 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
ICU MEDICAL SALES, INC. 85RR5 P/N NDC00990-7926-09
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016903599 0001 BX 1.000
SPE2DP-26-T-3538
SECTION B
PR: 7016903599 PRLI: 0001 CONT’D
NSN/MATERIAL:6505001161025
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
RDD 555 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
MARKFOR
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
M/F: (TCN) W50YF261410004
RDD: 555
PROJ: TP 3
SPE2DP-26-T-3538
SECTION B
PR: 7016903599 PRLI: 0001 CONT’D
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:05/27/2026
SPE2DP-26-T-3538 NSN/Part Number: 6505-00-116-1025 Quantity: 1 BX Purchase Request: 7016903599QTY: 1 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS